Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | 1444-1448 |
| Seitenumfang | 5 |
| Fachzeitschrift | CYTOTHERAPY |
| Jahrgang | 15 |
| Ausgabenummer | 12 |
| Frühes Online-Datum | 28 Aug. 2013 |
| Publikationsstatus | Veröffentlicht - Dez. 2013 |
Abstract
On October 11, 2012, two FP7-funded Research Consortia, CONTRACT (Consent in a Trial and Care Environment) and Academic GMP, held a Joint Conference in Brussels entitled "The Impact of EU Legislation on Therapeutic Advance." Academic researchers including stem cell transplant physicians and cell therapy specialists, legal advocates and representatives from industry, regulatory authorities and patient advocacy groups met with members of the European Parliament and the European Commission. This article summarizes important points of discussion and detailed proposals for improvement.
ASJC Scopus Sachgebiete
- Medizin (insg.)
- Immunologie und Allergologie
- Immunologie und Mikrobiologie (insg.)
- Immunologie
- Medizin (insg.)
- Onkologie
- Medizin (insg.)
- Genetik (klinisch)
- Biochemie, Genetik und Molekularbiologie (insg.)
- Zellbiologie
- Biochemie, Genetik und Molekularbiologie (insg.)
- Krebsforschung
- Medizin (insg.)
- Transplantationsmedizin
Ziele für nachhaltige Entwicklung
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: CYTOTHERAPY, Jahrgang 15, Nr. 12, 12.2013, S. 1444-1448.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Joint conference on the impact of EU legislation on therapeutic advance
AU - Forgó, Nikolaus
AU - Hildebrandt, Martin
N1 - Funding Information: The research presented in this article has received funding from the European Union's Seventh Framework Programme ( FP7/2007-2013 ) under grant agreements No. 260773 (Academic GMP) and 261412 (CONTRACT).
PY - 2013/12
Y1 - 2013/12
N2 - On October 11, 2012, two FP7-funded Research Consortia, CONTRACT (Consent in a Trial and Care Environment) and Academic GMP, held a Joint Conference in Brussels entitled "The Impact of EU Legislation on Therapeutic Advance." Academic researchers including stem cell transplant physicians and cell therapy specialists, legal advocates and representatives from industry, regulatory authorities and patient advocacy groups met with members of the European Parliament and the European Commission. This article summarizes important points of discussion and detailed proposals for improvement.
AB - On October 11, 2012, two FP7-funded Research Consortia, CONTRACT (Consent in a Trial and Care Environment) and Academic GMP, held a Joint Conference in Brussels entitled "The Impact of EU Legislation on Therapeutic Advance." Academic researchers including stem cell transplant physicians and cell therapy specialists, legal advocates and representatives from industry, regulatory authorities and patient advocacy groups met with members of the European Parliament and the European Commission. This article summarizes important points of discussion and detailed proposals for improvement.
KW - ATMP
KW - Clinical trial
KW - European Union
KW - Informed consent
UR - http://www.scopus.com/inward/record.url?scp=84887115967&partnerID=8YFLogxK
U2 - 10.1016/j.jcyt.2013.06.011
DO - 10.1016/j.jcyt.2013.06.011
M3 - Article
C2 - 23992669
AN - SCOPUS:84887115967
VL - 15
SP - 1444
EP - 1448
JO - CYTOTHERAPY
JF - CYTOTHERAPY
SN - 1465-3249
IS - 12
ER -